Paluray, Remegio S.

HRN: 22-17-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2022
CEFTRIAXONE 1G (VIAL)
11/15/2022
11/17/2022
IVT
2g
Od X 3 Days More
Alcoholic Liver Disease
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: